Kinderneusspray Xylometazoline Hcl Etos

Xylometazoline Hydrochloride, the active ingredient in Kinderneusspray Xylometazoline Hcl Etos, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion effectively and improves breathing during episodes caused by the common cold, sinusitis, and allergic rhinitis in children and adults.

GNH USA supplies Kinderneusspray Xylometazoline Hcl Etos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with rigorous quality assurance and regulatory compliance across multiple regions, ensuring consistent product availability globally.

Xylometazoline Hydrochloride is used as a nasal decongestant to relieve swelling of the nasal mucosa in several upper‑respiratory conditions.

- Common cold nasal congestion: reduces mucosal edema to improve airflow. - Sinusitis‑related congestion: alleviates blockage and pressure within sinus passages. - Allergic rhinitis: decreases nasal swelling caused by allergen exposure.

Xylometazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing. - Headache. - Altered taste perception. - Minor nosebleeds.

Serious or Rare Side Effects: - Severe hypertension. - Tachycardia or arrhythmia. - Rebound nasal congestion after prolonged use. - Allergic reactions such as rash or swelling. - Nasal ulceration. - Persistent or heavy nosebleeds.

When using Xylometazoline Hydrochloride nasal spray, consider the following safety measures.

- Use in children under 6 years: not recommended unless directed by a physician. - Duration of use: limit to 3‑5 days to avoid rebound congestion. - Existing cardiovascular disease: consult a healthcare professional before use. - Pregnancy and breastfeeding: discuss potential risks with a doctor. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other medications, affecting cardiovascular and systemic responses.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstriction can lead to excessive hypertension. - Systemic sympathomimetics: may cause excessive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: may reduce blood‑pressure control efficacy. - Central nervous system stimulants: monitor for increased heart rate and blood pressure. - Certain antidepressants: observe for any unexpected cardiovascular effects.